20th September 2021

Cell Therapy to Address Treatment Gap Between Pain Management and End-stage Surgery for Chronic Degenerative Diseases

Download the white paper below:                                       

17th May 2022

Dr. Manish Gupta joins the GIDOA-03 team

Dr. Manish Gupta, an orthopaedic surgeon with a sports medicine focus enters as GID BIO’s newest principal investigator in a pivotal Phase III trial

10th March 2022

Research on pain management, the treatment gap, and cellular therapy

There is much to discover about how cell therapy has the potential to close the treatment gap between pain management and major surgery.  Our

23rd December 2021

The FDA approval process is important for patient safety and cell therapy research

In 2017, the Food and Drug Administration gave for-profit stem cell clinics three years to engage the regulatory approval process to establish the safety

10th December 2021

Two new employees join GID BIO team

Stephen Smith and Amanda Lark are GID BIO’s newest employees GID BIO welcomes two new employees to the team as the newest of eight

22nd November 2021

GID BIO CEO William Cimino, PhD, moderates panel at recent IFATS conference

GID BIO CEO William Cimino, Ph.D., moderated the Industry Showcase panel at the recent 18th annual International Federation for Adipose Therapeutics and Science (IFATS)

29th October 2021

FDA announces consolidation of regulatory oversight responsibilities for fat transfer devices that process adipose tissue for return to the body

The proper surveillance of medical devices is necessary to ensure the health and safety of the public, and the Food and Drug Administration is